Milano
Italy
10
2026-05-28
4
2025-07-22
These are the the leading inventors for applications assigned to Epitech Group S.P.A.:
Epitech Group S.P.A. based in Milano, IT has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
2-PENTADECYL-2-OXAZOLINE IN ASSOCIATION WITH BUTYRIC ACID OR A SALT THEREOF IN THE TREATMENT OF EPILEPSY
#2 | 2026-01-222-PENTADECYL-2-OXAZOLINE AS AN OPIOID ADJUVANT TO PREVENT OR TREAT HYPERALGESIA
#3 | 2024-09-26Adelmidrol For Use In Diseases Characterized By Insufficient Agonism Of PPAR-GAMMA Receptor
#4 | 2023-09-14 ✅ Patent 12,364,678 granted on 2025-07-22PHARMACEUTICAL COMPOSITION COMPRISING PALMITOYLETHANOLAMIDE AND L-ACETYLCARNITINE
#5 | 2022-12-29COMPOSITION OF N-PALMITOYL-ETHANOLAMIDE AND BAICALEIN IN CO-MICRONIZED FORM
#6 | 2022-12-01 ✅ Patent 12,102,608 granted on 2024-10-01Composition of acylethanolamides from olive oil fatty acids
#7 | 2022-09-29 ✅ Patent 12,370,157 granted on 2025-07-29METHOD FOR THE TREATMENT OF COVID-19 INFECTIONS WITH PALMITOYLETHANOLAMIDE
#8 | 2021-06-10Adelmidrol For Use In Diseases Characterized By Insufficient Agonism Of PPAR-GAMMA Receptor
#9 | 2019-07-25 ✅ Patent 11,491,122 granted on 2022-11-08Use of a combination of Adelmidrol and hyaluronic acid in the treatment of pain caused by osteoarthritis and epithelial dysfunctions
#10 | 2017-05-04Adelmidrol For Use In Diseases Characterized By Insufficient Agonism Of PPAR-GAMMA Receptor
Also check out Epitech Group S.P.A.'s (Milano, Italy) applicant profile with 3 patent applications submitted.
121621 ⎘